32 completed, 4 terminated, 4 unknown, 2 recruiting. 34 Not applicable, 6 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 34 | Completed 24, Terminated 4, Unknown 4, Recruiting 2 |
| Phase 2 | 6 | Completed 6 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Glutens: new trials by email Literature Review of Glutens trials Research Report on Glutens
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease Placebo, Gluten 50 mg, Gluten 5 g - Celiac Disease, Gluten Sensitivity | Not applicable | Recruiting | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 51 | 2025-07-07 | 2026-04-27 |
| Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients With Non-celiac Gluten Sensitivity gluten, cornstarch - Type 2 Diabetes, Non Celiac Gluten Sensitivity | Not applicable | Completed | National Nutrition and Food Technology Institute | 40 | 2025-03-01 | 2026-08-06 |
| Effects of Gluten Free Diet in Ulcerative Colitis High gluten diet, Gluten free diet - Inflammatory Bowel Diseases, Ulcerative Colitis | Not applicable | Completed | University of Southern Denmark | 15 | 2024-03-11 | 2026-01-12 |
| Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients? Wheat gluten 1000 mg, Barley gluten 1000 mg, Barley gluten 50 mg - Celiac Disease, Food Intolerance | Not applicable | Completed | Oslo University Hospital | 33 | 2024-01-01 | 2026-04-24 |
| Gfree - For Improved Blood Sugar and Reduced Inflammation. gluten-free, probiotic, gluten - Diabetes, Celiac Disease | Not applicable | Recruiting | Göteborg University | 60 | 2023-05-04 | 2024-10-15 |
| Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission Ritlecitinib, Placebo, Gluten - Celiac Disease | Phase 2 | Completed | Massachusetts General Hospital | 62 | 2023-03-01 | 2026-09-15 |
| Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet Placebo, TAK-101, Gluten - Celiac Disease | Phase 2 | Completed | Takeda | 102 | 2022-06-23 | 2026-10-06 |
| Use of a Selected Mixture of Probiotic Strains for Degrading Gluten During Digestion Probiotic administration and gluten, Placebo administration and gluten - Probiotics | Not applicable | Completed | Free University of Bozen-Bolzano | 70 | 2020-10-01 | 2023-04-04 |
| Diagnostic Performance of Urinary Gluten Immunogenic Peptides in Monitoring the Adherence to Gluten-free Diet. Gluten (behaviour), Placebo (behaviour) - Celiac Disease | Not applicable | Completed | Università Politecnica delle Marche | 25 | 2020-10-01 | 2024-12-09 |
| Gluten-free Diet in Women With Autoimmune Thyroiditis Gluten-free diet, Gluten capsules supplementation, Placebo capsules supplementation - Autoimmune Thyroiditis | Not applicable | Completed | Medical University of Gdansk | 31 | 2020-09-22 | 2024-02-08 |
| Calorie Restriction in Multiple Sclerosis Caloric restriction, Caloric restriction without cow's milk and gluten - Multiple Sclerosis, Relapsing-Remitting, Caloric Restriction | Not applicable | Unknown | Federico II University | 93 | 2020-07-14 | 2024-08-20 |
| Gluten and (Extra-)Intestinal Symptoms in NCGS Expectancy and gluten - Non-celiac Gluten Sensitivity | Not applicable | Completed | Maastricht University | 84 | 2018-10-19 | 2023-03-22 |
| Identification of IBS Metabotypes Based on Physiological Responses to Food FODMAP, Gluten, Placebo - Irritable Bowel Syndrome | Not applicable | Completed | Uppsala University | 110 | 2018-09-10 | 2019-09-25 |
| Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge Gluten - Celiac Disease | Not applicable | Completed | Takeda | 16 | 2018-04-24 | 2022-05-24 |
| Gluten and Amylase Trypsin Inhibitors (ATI) Free Diet Gluten and Amylase Trypsin Inhibitors (ATI)-free diet - Type1diabetes | Not applicable | Completed | Medical College of Wisconsin | 32 | 2018-01-01 | 2025-04-29 |
| Changes in Intestinal Permeability 4 Hours After Gluten Challenge Gluten, Placebo - Celiac Disease, Wheat Hypersensitivity | Not applicable | Completed | Mayo Clinic | 60 | 2017-10-10 | 2019-06-07 |
| Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity Gluten, Placebo - NCGS, Gluten | Not applicable | Unknown | Universitaire Ziekenhuizen KU Leuven | 20 | 2017-05-11 | 2019-01-09 |
| Gluten Sensibility in Elite Athletes Gluten, Gluten free - Intestinal Diseases, Gluten-sensitive | Not applicable | Completed | University Hospital, Clermont-Ferrand | 51 | 2017-04-01 | 2026-08-06 |
| Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects Gluten, Placebo - Healthy Volunteers, Gluten | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 20 | 2017-02-16 | 2019-01-09 |
| The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission CDED + milk fat and gluten - Crohn's Disease | Not applicable | Terminated | Wolfson Medical Center | 10 | 2017-01-01 | 2022-06-01 |
Showing 20 of 42. Sign in to see all of them.
Celiac Disease (20) · Irritable Bowel Syndrome (4) · Autistic Disorder (3) · Autoimmune Diseases (2) · Diabetes Mellitus, Type 2 (2) · Inflammation (2) · Metabolic Syndrome (2) · Abdominal Pain (1) · Atherosclerosis (1) · Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Diabetes Mellitus (1) · Duodenal Diseases (1)
Aarhus University Hospital (3) · 9 Meters Biopharma, Inc. (2) · Beth Israel Deaconess Medical Center (2) · Massachusetts General Hospital (2) · Takeda (2) · Universitaire Ziekenhuizen KU Leuven (2) · Università Politecnica delle Marche (2) · All India Institute of Medical Sciences (1) · Center for Autisme, Denmark (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Federal University of Minas Gerais (1) · Federico II University (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Free University of Bozen-Bolzano (1) · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)
United States (14) · Italy (8) · Denmark (4) · Canada (3) · Sweden (3) · Belgium (2) · France (2) · Netherlands (2) · Australia (1) · Brazil (1) · Germany (1) · India (1) · Iran (1) · Israel (1) · New Zealand (1)
Daniel A Leffler, MD, MS (2) · Alberto Lanzini, MD, PhD (1) · Aleksandra Rodziewicz, MSc (1) · Alessio Fasano, M.D. (1) · Alessio Fasano, MD (1) · Anil K Verma, PHD (1) · Anna Sapone, MD, PhD (1) · Arie Levine, MD (1) · Barbara Zanini, MD, PhD (1) · Carlo Catassi, M.D. (1) · Carlo Catassi, MD, MPH (1) · Chiara Monachesi, PHD (1) · Chiara Ricci, MD, PhD (1) · Ciaran P Kelly, MD (1)
PMID 40138597, PMID 12531880, PMID 15788534, PMID 16410832, PMID 17143095, PMID 17183309, PMID 18056028, PMID 18673466, PMID 19445821, PMID 19458012, PMID 19665584, PMID 20406576, PMID 21327021, PMID 21409315, PMID 21885731, PMID 21893493, PMID 22011432, PMID 22542995, PMID 22619366, PMID 22644837, PMID 22752636, PMID 23163616, PMID 23370376, PMID 25701700, PMID 26416813, PMID 26653757, PMID 26976734, PMID 27102333, PMID 27256300, PMID 28903182, PMID 29044230, PMID 29320965, PMID 29380821, PMID 29460921, PMID 30060266, PMID 33130104, PMID 33482041, PMID 33746942, PMID 34362024, PMID 34613954, PMID 34617561, PMID 34797778, PMID 35140703, PMID 35973395, PMID 36087104, PMID 37399002, PMID 38040019, PMID 38347192, PMID 39209203, PMID 40805974
K23DK082619 (1), U54MH066397 (1)